Overview of Dr. Johnson Dr. Ronald Johnson is a general surgeon in Pittsburgh, PA and is affiliated with multiple hospitals in the area, including UPMC Presbyterian and UPMC Magee-Womens Hospital. He received his medical degree from University of Pittsburgh School of Medicine and has been in practice 34 years. Dr. Johnson accepts several types of health insurance, listed below. He is one of 51 doctors at UPMC Magee-Womens Hospital and one of 183 doctors at UPMC Presbyterian who specialize in General Surgery.
Education & Training University of Pittsburgh Medical Center Residency, General Surgery, 1983 - 1988
University of Pittsburgh School of Medicine Class of 1983
Certifications & Licensure Awards, Honors, & Recognition Fellow (FACS) American College of Surgeons Publications & Presentations PubMed
Is multifocal regression a risk factor for ipsilateral breast tumor recurrence in the modern era after neoadjuvant chemotherapy and breast conservation therapy?
Ling, D. C.,Sutera, P. A.,Iarrobino, N. A.,Diego, E. J.,Soran, A.,Johnson, R. R.,Bhargava, R.,Champ, C. E.,Beriwal, S.> ;Int. J. Radiat. Oncol. Biol. Phys.. 2019 Mar 20 Magee Equation 3 predicts pathologic response to neoadjuvant systemic chemotherapy in estrogen receptor positive, HER2 negative/equivocal breast tumors.
Farrugia, D. J.,Landmann, A.,Zhu, L.,Diego, E. J.,Johnson, R. R.,Bonaventura, M.,Soran, A.,Dabbs, D. J.,Clark, B. Z.,Puhalla, S. L.,Jankowitz, R. C.,Brufsky, A. M.,Lem...> ;Mod. Pathol.. 2017 May 27 Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatme...
Diego, E. J.,McAuliffe, P. F.,Soran, A.,McGuire, K. P.,Johnson, R. R.,Bonaventura, M.,Ahrendt, G. M.> ;Ann. Surg. Oncol.. 2016 Jan 06 Breast cancer-related lymphedema after axillary lymph node dissection: does early postoperative prediction model work?
Soran, A.,Menekse, E.,Girgis, M.,DeGore, L.,Johnson, R.> ;Support Care Cancer. 2015 Sep 10 The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospecti...
Soran, A.,Ozmen, T.,McGuire, K. P.,Diego, E. J.,McAuliffe, P. F.,Bonaventura, M.,Ahrendt, G. M.,DeGore, L.,Johnson, R.> ;Lymphat Res Biol. 2014 Dec 17 Localizing High-Risk Lesions for Excisional Breast Biopsy: A Comparison Between Radioactive Seed Localization and Wire Localization.
Diego, E. J.,Soran, A.,McGuire, K. P.,Costellic, C.,Johnson, R. R.,Bonaventura, M.,Ahrendt, G. M.,McAuliffe, P. F.> ;Ann. Surg. Oncol.. 2014 Jul 19 Increasing trend of contralateral prophylactic mastectomy: What are the factors behind this phenomenon?
Soran, A.,Kamali Polat, A.,Johnson, R.,McGuire, K. P.> ;Surgeon. 2014 Apr 02 Extended (5-year) outcomes of accelerated partial breast irradiation using MammoSite balloon brachytherapy: patterns of failure, patient selection, and dosimetric corr...
Vargo, J. A.,Verma, V.,Kim, H.,Kalash, R.,Heron, D. E.,Johnson, R.,Beriwal, S.> ;Int. J. Radiat. Oncol. Biol. Phys.. 2013 Nov 26 Factors affecting cosmesis after breast conserving surgery without oncoplastic techniques in an experienced comprehensive breast center.
Ozmen, T.,Polat, A. V.,Polat, A. K.,Bonaventura, M.,Johnson, R.,Soran, A.> ;Surgeon. 2014 Feb 18 Margin width is not predictive of residual disease on re-excision in breast conserving therapy.
Hadzikadic Gusic, L.,McGuire, K. P.,Ozmen, T.,Soran, A.,Thomas, C. R.,McAuliffe, P. F.,Diego, E. J.,Bonaventura, M.,Johnson, R. R.,Ahrendt, G. M.> ;J Surg Oncol. 2013 Dec 18 Predictors of pathologic complete response after standard neoadjuvant chemotherapy in triple-negative breast carcinoma.
Kraus, J. A., Beriwal, S., Dabbs, D. J., Ahrendt, G. M., McGuire, K. P., Johnson, R. R., Badve, P., Puhalla, S. L., Bhargava, R.> ;Appl Immunohistochem Mol Morphol. 2012 Jul Atypical hyperplasia on core biopsy: is further surgery needed?
Polat, A. K., Kanbour-Shakir, A., Andacoglu, O., Polat, A. V., Johnson, R., Bonaventura, M., Soran, A.> ;Am J Med Sci. 2012 Jul Molecular Class as a Predictor of Locoregional and Distant Recurrence in the Neoadjuvant Setting for Breast Cancer.
Vargo, J.A., Beriwal, S., Ahrendt, G.M., Soran, A., Johnson, R.R., McGuire, K., Bhargava, R.> ;Oncology. 2011 Semiquantitative hormone receptor level influences response to trastuzumab-containing neoadjuvant chemotherapy in HER2-positive breast cancer.
Bhargava, R., Dabbs, D.J., Beriwal, S., Yildiz, I.A., Badve, P., Soran, A., Johnson, R.R., Brufsky, A.M., Lembersky, B.C., McGuire, K.P., Ahrendt, G.M.> ;Mod Pathol. 2011 Mar Nucleotide excision repair deficiency is intrinsic in sporadic stage I breast cancer.
Latimer, J.J., Johnson, J.M., Kelly, C.M., Miles, T.D., Beaudry-Rodgers, K.A., Lalanne, N.A., Vogel, V.G., Kanbour-Shakir, A., Kelley, J.L., Johnson, R.R., Grant, S.G.> ;Proc Natl Acad Sci U S A. 2010 Dec 14 Erratum: Immunohistochemical Surrogate Markers of Breast Cancer Molecular Classes Predicts Response to Neoadjuvant Chemotherapy.
Bhargava, R., Beriwal, S., Dabbs, D.J., Ozbek, U., Soran, A., Johnson, R.R., Brufsky, A.M., Lembersky, B.C., Ahrendt, G.M.> ;Cancer. 2010-11-10 Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy: a single institutional experience with 359 cases.
Bhargava, R., Beriwal, S., Dabbs, D.J., Ozbek, U., Soran, A., Johnson, R.R., Brufsky, A.M., Lembersky, B.C., Ahrendt, G.M.> ;Cancer. 2010 Mar 15 Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
Unal, B.,Gur, A. S.,Beriwal, S.,Tang, G.,Johnson, R.,Ahrendt, G.,Bonaventura, M.,Soran, A.> ;Int. J. Radiat. Oncol. Biol. Phys.. 2009 Nov 15 Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.
Gur, A. S.,Unal, B.,Johnson, R.,Ahrendt, G.,Bonaventura, M.,Gordon, P.,Soran, A.> ;J. Am. Coll. Surg.. 2009 Feb 21 Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
Rutstein, L.A., Johnson, R.R., Poller, W.R., Dabbs, D., Groblewski, J., Rakitt, T., Tsung, A., Kirchner, T., Sumkin, J., Keenan, D., Soran, A., Ahrendt, G., Falk, J.S.> ;Breast J. 2007-05-01 Breast cancer-related lymphedema--what are the significant predictors and how they affect the severity of lymphedema?
Soran, A., D'Angelo, G., Begovic, M., Ardic, F., Harlak, A., Samuel Wieand, H., Vogel, V.G., Johnson, R.R.> ;Breast J. 2006-11-01 Preemptive analgesia with bupivacaine for segmental mastectomy.
Vallejo, M.C., Phelps, A.L., Sah, N., Romeo, R.C., Falk, J.S., Johnson, R.R., Keenan, D.M., Bonaventura, M.A., Edington, H.D.> ;Reg Anesth Pain Med. 2006-05-01 The importance of pre-operative needle core breast biopsy results on resected tissue volume, margin status, and cosmesis.
Polat, A. V.,Soran, A.,Andacoglu, O.,Kamali Polat, A.,McGuire, K.,Diego, E.,Johnson, R.> ;J BUON. 2013 Sep 26 Factors that predict the burden of axillary disease in breast cancer patients with a positive sentinel node.
Beriwal, S., Soran, A., Kocer, B., Wilson, J. W., Ahrendt, G. M., Johnson, R.> ;Am J Clin Oncol. 2008 Feb Join now to see all Insurance Accepted Aetna Choice POS II Aetna HMO BCBS Blue Card PPO CIGNA HMO CIGNA Open Access CIGNA PPO Great West PPO HealthAmerica HealthAssurance PPO
Highmark BCBS ClassicBlue Highmark BCBS PPOBlue Humana ChoiceCare Network PPO Multiplan PHCS PPO Multiplan PPO United Healthcare - Direct Choice Plus POS United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment